On Jun 2 , Dr. Daud's Abstract poster with ALL of the additional clinical trials details will be on display at ASCO. The Abstract is a very brief summary only. There is a ton of more details available on the poster that will be available to the public on Jun 2, and NOT before. On Jun 2 Dr.Daud for 2 to 3 hrs will be answering ALL of the Pharma executives questions that have come to view the complete details. Meetings will be set up following the Poster Presentation for private one-on-one discussions with $ONCS management for Partnership discussions.
After Jun 2, the world will know the complete details of $ONCS successful Melanoma Phase2A details.
I know you are just trolling, but pretty amazing how you fail to comprehend the fact that 98% of the investment public does not go seeking abstracts and the data inside them, especially for micro cap OTC's. When the results are released through a PR, trust me, the market will take notice.